Observation on the Nursing Effect of the Whole Process in Patients with Severe Intracranial Hemorrhage

Abstract

Objective. The goal of this study was to look at the clinical impact of the entire process of nursing care for patients with severe cerebral hemorrhage. Method. From January 2018 to December 2019, the clinical data of 160 patients with severe cerebral hemorrhage who were hospitalized to our hospital were reviewed retrospectively. They were separated into two groups based on their admission: routine and complete procedure. The routine group used routine emergency care, the whole process group was provided first aid care with whole process nursing. The diagnosis and treatment time, the success rate of emergency care, the incidence of adverse events, and the complaint rate were compared between the two groups. Results. The treatment time, emergency examination time, and preoperative rescue time of emergency patients in the whole process group were significantly shorter than those in the conventional group, with statistically significant differences (all $P<0.05$ ). The rescue success rate of emergency patients in the whole process group was 95.00% (76/80), and the rescue success rate of emergency patients in the routine group was 83.75% (67/80); the difference was statistically significant ( ${\chi }^2=4.378$ , $P=0.034$ ). The complaint rate of emergency patients in the whole process group was 2.50% (2/80), while that in the routine group was 8.75% (7/80), with statistically significant difference ( ${\chi }^2=4.732$ , $P=0.024$ ). The incidence of total nursing adverse events was 6.25% (5/80) in the whole process group and 17.50% (14/80) in the routine group; the difference was statistically significant ( ${\chi }^2=5.011$ , $P=0.027$ ). Conclusion. The implementation of whole process nursing care for patients with severe intracranial hemorrhage can shorten the time-consuming first aid for patients with intracranial hemorrhage. And it also can improve the rescue success rate of patients and reduce the incidence of adverse events and complaints, which represents a significant clinical application effect.